Valuation (41%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 43.61 | 46.69 |
PEG Ratio (TTM) | -1.92 | 0.54 |
P/S Ratio (TTM) | 8.74 | 18.38 |
P/B Ratio (TTM) | 8.19 | 15.90 |
P/FCF Ratio (TTM) | 33.61 | 40.59 |
Price to 5YR AVG Earnings Ratio | 2,048.32 | 73.07 |
Price to 5YR AVG FCF Ratio | 57.16 | 99.79 |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | 9.87% | -2.60% |
ROE (TTM) | 19.52% | 9.17% |
Net Profit Margin (TTM) | 19.92% | 4.25% |
ROIC 5YR AVG | -3.14% | 5.27% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 232.75% | 48.04% | -137.85% |
Revenue | 3.74% | 22.19% | 20.86% |
Net Income | 230.95% | 45.53% | -150.30% |
Cash Flow | 20.71% | 39.79% | 29.89% |
Health (81%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.05 | 1.89 |
Quick Ratio (TTM) | 2.05 | 1.88 |
D/E Ratio (TTM) | 0.04 | 0.52 |
Interest Coverage (TTM) | 3.50 | 12.73 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 6.35 | 10.72 |
LTL to 5YR AVG FCF | 2.58 | 3.91 |
Shares Outstanding Growth 5YR AVG | 3.81% | 49.72% |